IMMUNITY SUPPORT INGREDIENTS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-09-13 |   Pages: 200+ |   Report ID: 185125 |   Healthcare

Historical data: 2018 - 2024

Forecast period: 2025 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Immunity Support Ingredients Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL IMMUNITY SUPPORT INGREDIENTS MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL IMMUNITY SUPPORT INGREDIENTS MARKET

7.1 GLOBAL IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA IMMUNITY SUPPORT INGREDIENTS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 DSM

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 BASF

16.3 Zhejiang NHU

16.4 Croda

16.5 CSPC Pharma

16.6 EPAX

16.7 Adisseo

16.8 Zhejiang Medicine

16.9 Raisio Group

16.10 Northeast Pharma

16.11 Shandong Luwei

16.12 Allied Biotech

16.13 Cargill

16.14 Anhui Tiger

16.15 Shandong Tianli

16.16 Kerry

16.17 Dohler

16.18 Kemin

16.19 Chenguang Biotech

16.20 FMC

16.21 Chr. Hansen

16.22 Excelvite

16.23 DDW

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Vitamin C
Vitamin E
Other Vitamins
Beta Glucans
Carotenoids
Phytosterols
Omega-3 Fatty Acids
Others

By Application
Nutrition Supplements
Foods & Beverages
Pharmaceuticals
Feeds
Pet Foods
Personal Care Products

Companies

DSM
BASF
Zhejiang NHU
Croda
CSPC Pharma
EPAX
Adisseo
Zhejiang Medicine
Raisio Group
Northeast Pharma
Shandong Luwei
Allied Biotech
Cargill
Anhui Tiger
Shandong Tianli
Kerry
Dohler
Kemin
Chenguang Biotech
FMC
Chr. Hansen
Excelvite
DDW

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.